Shadmehr Demehri, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Neoplasms | 21 | 2023 | 5318 | 3.020 |
Why?
|
Carcinoma, Squamous Cell | 9 | 2022 | 3994 | 1.800 |
Why?
|
Cytokines | 14 | 2022 | 7190 | 1.620 |
Why?
|
Skin | 10 | 2022 | 4298 | 1.200 |
Why?
|
Receptors, Notch | 6 | 2020 | 754 | 1.180 |
Why?
|
Dermatitis, Allergic Contact | 2 | 2019 | 103 | 1.100 |
Why?
|
Cancer Vaccines | 2 | 2022 | 997 | 1.040 |
Why?
|
Epidermis | 4 | 2019 | 539 | 0.950 |
Why?
|
Smad6 Protein | 1 | 2021 | 17 | 0.850 |
Why?
|
Killer Cells, Natural | 4 | 2023 | 2170 | 0.810 |
Why?
|
Alphapapillomavirus | 2 | 2020 | 226 | 0.800 |
Why?
|
Lichen Planus | 1 | 2020 | 55 | 0.740 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2022 | 3045 | 0.730 |
Why?
|
Melanoma, Experimental | 1 | 2023 | 556 | 0.720 |
Why?
|
Skin Physiological Phenomena | 1 | 2020 | 181 | 0.720 |
Why?
|
Langerhans Cells | 1 | 2019 | 177 | 0.710 |
Why?
|
Papillomaviridae | 3 | 2020 | 1139 | 0.690 |
Why?
|
Scleroderma, Systemic | 1 | 2022 | 295 | 0.690 |
Why?
|
Chemokines, CXC | 1 | 2019 | 442 | 0.660 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2018 | 64 | 0.650 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 842 | 0.640 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 760 | 0.630 |
Why?
|
Extracellular Matrix | 2 | 2022 | 1755 | 0.630 |
Why?
|
Symbiosis | 1 | 2019 | 295 | 0.610 |
Why?
|
Virus Diseases | 1 | 2022 | 698 | 0.590 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2023 | 873 | 0.580 |
Why?
|
Keratosis, Actinic | 1 | 2016 | 69 | 0.570 |
Why?
|
Immunity, Cellular | 3 | 2017 | 1684 | 0.570 |
Why?
|
Th2 Cells | 2 | 2022 | 1053 | 0.550 |
Why?
|
Immunotherapy | 5 | 2022 | 4095 | 0.530 |
Why?
|
Keratinocytes | 7 | 2023 | 797 | 0.500 |
Why?
|
Tumor Suppressor Proteins | 2 | 2016 | 2883 | 0.490 |
Why?
|
Organ Transplantation | 2 | 2022 | 1072 | 0.480 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2016 | 535 | 0.460 |
Why?
|
Precancerous Conditions | 2 | 2016 | 946 | 0.430 |
Why?
|
Mice | 27 | 2023 | 80375 | 0.420 |
Why?
|
Colitis | 1 | 2019 | 1136 | 0.400 |
Why?
|
Sarcoma | 1 | 2022 | 1878 | 0.400 |
Why?
|
HLA Antigens | 3 | 2023 | 1545 | 0.400 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2021 | 4262 | 0.390 |
Why?
|
Calcitriol | 4 | 2023 | 309 | 0.390 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 4 | 2020 | 147 | 0.380 |
Why?
|
Monocytes | 1 | 2019 | 2620 | 0.380 |
Why?
|
Health Promotion | 1 | 2022 | 2212 | 0.380 |
Why?
|
Melanoma | 3 | 2023 | 5250 | 0.370 |
Why?
|
Hair Follicle | 2 | 2009 | 217 | 0.370 |
Why?
|
Signal Transduction | 10 | 2022 | 23729 | 0.370 |
Why?
|
Receptor, Notch1 | 3 | 2010 | 519 | 0.370 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2023 | 4378 | 0.370 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1513 | 0.330 |
Why?
|
Lung Neoplasms | 2 | 2023 | 12539 | 0.330 |
Why?
|
Animals | 29 | 2023 | 169420 | 0.310 |
Why?
|
Inflammation | 4 | 2022 | 10081 | 0.310 |
Why?
|
Fluorouracil | 4 | 2023 | 1610 | 0.300 |
Why?
|
Leukemia, Mast-Cell | 1 | 2006 | 13 | 0.300 |
Why?
|
Dermatitis, Atopic | 2 | 2010 | 615 | 0.290 |
Why?
|
Immunocompromised Host | 2 | 2022 | 868 | 0.280 |
Why?
|
Genes, Tumor Suppressor | 1 | 2009 | 1092 | 0.260 |
Why?
|
Breast Neoplasms | 2 | 2022 | 20062 | 0.260 |
Why?
|
Stromal Cells | 2 | 2009 | 1338 | 0.260 |
Why?
|
Lymphoproliferative Disorders | 1 | 2008 | 539 | 0.260 |
Why?
|
Carcinogens | 2 | 2021 | 452 | 0.260 |
Why?
|
Mastocytosis | 1 | 2006 | 151 | 0.250 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 4980 | 0.240 |
Why?
|
Xeroderma Pigmentosum | 1 | 2023 | 33 | 0.240 |
Why?
|
Collagen | 2 | 2022 | 2667 | 0.240 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 6592 | 0.240 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11236 | 0.240 |
Why?
|
Humans | 42 | 2023 | 715777 | 0.230 |
Why?
|
Adaptive Immunity | 3 | 2019 | 702 | 0.230 |
Why?
|
Neoplasms | 5 | 2022 | 20528 | 0.220 |
Why?
|
Mice, Knockout | 9 | 2019 | 15059 | 0.210 |
Why?
|
Bleomycin | 1 | 2022 | 504 | 0.200 |
Why?
|
Cell Line, Tumor | 7 | 2022 | 16736 | 0.200 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 154 | 0.200 |
Why?
|
Antigens, Neoplasm | 2 | 2019 | 1987 | 0.200 |
Why?
|
Nevus, Pigmented | 1 | 2022 | 216 | 0.190 |
Why?
|
Interleukin-13 | 1 | 2022 | 367 | 0.190 |
Why?
|
Allergy and Immunology | 1 | 2021 | 176 | 0.190 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13626 | 0.190 |
Why?
|
Receptors, CCR6 | 1 | 2019 | 78 | 0.190 |
Why?
|
Mannose-Binding Lectins | 1 | 2019 | 104 | 0.180 |
Why?
|
Cell Lineage | 1 | 2009 | 2594 | 0.180 |
Why?
|
Paget Disease, Extramammary | 1 | 2019 | 39 | 0.180 |
Why?
|
Arginine | 1 | 2023 | 953 | 0.180 |
Why?
|
Cytomegalovirus | 1 | 2023 | 690 | 0.180 |
Why?
|
Chronic Disease | 4 | 2019 | 9030 | 0.180 |
Why?
|
Administration, Topical | 2 | 2019 | 701 | 0.170 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2018 | 167 | 0.170 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2022 | 1487 | 0.160 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 404 | 0.160 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 147 | 0.160 |
Why?
|
STAT3 Transcription Factor | 1 | 2022 | 891 | 0.160 |
Why?
|
DNA Virus Infections | 1 | 2017 | 16 | 0.160 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1597 | 0.160 |
Why?
|
Genes, MHC Class II | 1 | 2018 | 505 | 0.150 |
Why?
|
Th1 Cells | 1 | 2022 | 1074 | 0.150 |
Why?
|
Cell Count | 2 | 2019 | 1912 | 0.150 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18199 | 0.150 |
Why?
|
Lasers, Gas | 1 | 2017 | 97 | 0.150 |
Why?
|
Lectins, C-Type | 1 | 2019 | 606 | 0.150 |
Why?
|
Female | 19 | 2022 | 377204 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1897 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1396 | 0.140 |
Why?
|
Stem Cells | 1 | 2009 | 3569 | 0.140 |
Why?
|
Ligands | 1 | 2022 | 3294 | 0.140 |
Why?
|
B-Lymphocytes | 2 | 2008 | 4902 | 0.140 |
Why?
|
Fibrosis | 1 | 2022 | 1928 | 0.140 |
Why?
|
Epithelium | 1 | 2020 | 1721 | 0.130 |
Why?
|
Neutrophil Infiltration | 1 | 2017 | 400 | 0.130 |
Why?
|
Immunity | 2 | 2017 | 976 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1069 | 0.130 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22665 | 0.130 |
Why?
|
Disease Progression | 2 | 2020 | 13215 | 0.130 |
Why?
|
Nickel | 1 | 2014 | 131 | 0.130 |
Why?
|
Oncogenes | 1 | 2019 | 1246 | 0.120 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 520 | 0.120 |
Why?
|
Internal Fixators | 1 | 2014 | 190 | 0.120 |
Why?
|
Cell Differentiation | 4 | 2023 | 11655 | 0.120 |
Why?
|
Lymphocytes | 1 | 2021 | 2737 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 1974 | 0.120 |
Why?
|
Lasers | 1 | 2017 | 956 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 2985 | 0.110 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2807 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2021 | 2995 | 0.110 |
Why?
|
Psoriasis | 1 | 2020 | 974 | 0.110 |
Why?
|
Aged | 7 | 2023 | 162448 | 0.100 |
Why?
|
RNA, Viral | 1 | 2019 | 2838 | 0.100 |
Why?
|
Dermatitis | 1 | 2012 | 193 | 0.100 |
Why?
|
Pruritus | 1 | 2013 | 333 | 0.100 |
Why?
|
Neoplasm Metastasis | 1 | 2022 | 5074 | 0.100 |
Why?
|
Asthma | 1 | 2009 | 5946 | 0.100 |
Why?
|
Middle Aged | 8 | 2019 | 214639 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2005 | 784 | 0.100 |
Why?
|
Desmogleins | 1 | 2009 | 3 | 0.100 |
Why?
|
Dermatology | 1 | 2020 | 847 | 0.100 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2009 | 65 | 0.090 |
Why?
|
Genes, ras | 1 | 2012 | 706 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2021 | 2943 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58323 | 0.090 |
Why?
|
Sensory Receptor Cells | 1 | 2013 | 445 | 0.090 |
Why?
|
Up-Regulation | 1 | 2019 | 4312 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 1941 | 0.090 |
Why?
|
Cell Line | 2 | 2021 | 16576 | 0.090 |
Why?
|
Lung | 2 | 2023 | 9735 | 0.090 |
Why?
|
Antigens, CD | 1 | 2019 | 4152 | 0.090 |
Why?
|
Epithelial Cells | 1 | 2021 | 3638 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2019 | 2699 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2118 | 0.080 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9849 | 0.080 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 865 | 0.080 |
Why?
|
Keratins | 1 | 2009 | 528 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3428 | 0.080 |
Why?
|
Cell Movement | 1 | 2019 | 5397 | 0.080 |
Why?
|
Osteopontin | 1 | 2009 | 352 | 0.080 |
Why?
|
Hair | 1 | 2009 | 444 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3268 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2533 | 0.070 |
Why?
|
Mice, Inbred DBA | 1 | 2006 | 666 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2019 | 11945 | 0.070 |
Why?
|
Hypersensitivity | 1 | 2013 | 1034 | 0.070 |
Why?
|
Neutrophils | 1 | 2017 | 3800 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3346 | 0.060 |
Why?
|
Palliative Care | 1 | 2019 | 3286 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2008 | 1660 | 0.060 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2008 | 607 | 0.060 |
Why?
|
Myeloproliferative Disorders | 1 | 2010 | 604 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4375 | 0.060 |
Why?
|
Male | 9 | 2021 | 350324 | 0.060 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2005 | 422 | 0.060 |
Why?
|
Apoptosis | 1 | 2019 | 9973 | 0.060 |
Why?
|
Survival Analysis | 3 | 2017 | 10499 | 0.060 |
Why?
|
Animals, Newborn | 1 | 2008 | 2840 | 0.060 |
Why?
|
Age Factors | 1 | 2019 | 18784 | 0.060 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2023 | 127 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 4881 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2008 | 10620 | 0.050 |
Why?
|
Gene Deletion | 1 | 2009 | 2824 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2006 | 1894 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2017 | 6641 | 0.050 |
Why?
|
Longevity | 1 | 2008 | 1030 | 0.050 |
Why?
|
Pyrimidinones | 1 | 2023 | 373 | 0.050 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2005 | 673 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 617 | 0.050 |
Why?
|
Cell Communication | 1 | 2007 | 1635 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2442 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2010 | 6093 | 0.040 |
Why?
|
Azacitidine | 1 | 2020 | 298 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2005 | 2023 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15603 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 692 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2022 | 2124 | 0.040 |
Why?
|
Photolysis | 1 | 2017 | 91 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 278 | 0.040 |
Why?
|
Blotting, Western | 1 | 2006 | 5379 | 0.040 |
Why?
|
Homeostasis | 1 | 2009 | 3332 | 0.040 |
Why?
|
Piperazines | 2 | 2005 | 2524 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 12305 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5412 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1633 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2017 | 808 | 0.030 |
Why?
|
Gene Frequency | 2 | 2017 | 3722 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 51315 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1904 | 0.030 |
Why?
|
Gastrin-Releasing Peptide | 1 | 2013 | 37 | 0.030 |
Why?
|
Receptors, Bombesin | 1 | 2013 | 27 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3898 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1323 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 56226 | 0.030 |
Why?
|
Pyrimidines | 1 | 2005 | 2930 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2551 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2013 | 233 | 0.030 |
Why?
|
Leadership | 1 | 2021 | 1344 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1046 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 1900 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4647 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2023 | 3063 | 0.030 |
Why?
|
Genotype | 2 | 2018 | 12919 | 0.030 |
Why?
|
Mutation | 3 | 2023 | 29291 | 0.030 |
Why?
|
Autoimmunity | 1 | 2019 | 1328 | 0.030 |
Why?
|
Epitopes | 1 | 2017 | 2649 | 0.030 |
Why?
|
Laser Therapy | 1 | 2017 | 1070 | 0.020 |
Why?
|
Nociceptors | 1 | 2013 | 441 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2005 | 5198 | 0.020 |
Why?
|
Receptor, Notch2 | 1 | 2010 | 93 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 11953 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2330 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 269 | 0.020 |
Why?
|
Risk Factors | 4 | 2020 | 70866 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 6009 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2018 | 11940 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 403 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3741 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2099 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 636 | 0.020 |
Why?
|
Somatomedins | 1 | 2007 | 196 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2013 | 1496 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 2804 | 0.020 |
Why?
|
Pregnancy | 1 | 2008 | 27398 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3451 | 0.020 |
Why?
|
DNA Methylation | 1 | 2020 | 4078 | 0.020 |
Why?
|
Adult | 2 | 2019 | 212266 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9377 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 2007 | 422 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2010 | 919 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1203 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1571 | 0.020 |
Why?
|
Time Factors | 1 | 2008 | 40875 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4352 | 0.020 |
Why?
|
Spinal Cord | 1 | 2013 | 1808 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3738 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2009 | 1582 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2004 | 369 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8571 | 0.020 |
Why?
|
Melanocytes | 1 | 2007 | 521 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2004 | 189 | 0.020 |
Why?
|
Karyotyping | 1 | 2005 | 1266 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3801 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1116 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4893 | 0.010 |
Why?
|
Mitosis | 1 | 2007 | 1248 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 7099 | 0.010 |
Why?
|
Clone Cells | 1 | 2005 | 1760 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10284 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16311 | 0.010 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 657 | 0.010 |
Why?
|
Mutagenesis | 1 | 2005 | 1281 | 0.010 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2004 | 483 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7954 | 0.010 |
Why?
|
Benzamides | 1 | 2005 | 1390 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6803 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2005 | 1726 | 0.010 |
Why?
|
Fibroblasts | 1 | 2009 | 4233 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3964 | 0.010 |
Why?
|
Quinazolines | 1 | 2004 | 1408 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40029 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 62004 | 0.010 |
Why?
|
Cell Division | 1 | 2005 | 4699 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2007 | 2947 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 2562 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4296 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2766 | 0.010 |
Why?
|
Cell Cycle | 1 | 2004 | 2993 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2004 | 4824 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2465 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 13206 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7885 | 0.010 |
Why?
|
Graft Survival | 1 | 2004 | 3750 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8658 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9809 | 0.010 |
Why?
|
Rats | 1 | 2009 | 24860 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12480 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 72443 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14902 | 0.010 |
Why?
|
United States | 1 | 2017 | 67905 | 0.010 |
Why?
|